Hanall Biopharma (009420) — Strategic Asset Allocation Index
Hanall Biopharma (009420) has a Strategic Asset Allocation Index of 11.4% as of December 2022. Strategic assets (PP&E of ₩19.13 Billion plus long-term investments of ₩-) total ₩19.13 Billion, measured against net assets of ₩168.26 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 009420 equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Hanall Biopharma Strategic Asset Allocation Index (2011–2022)
This chart shows how Hanall Biopharma's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of December 2022, the index stands at 11.4%, representing strategic assets of ₩19.13 Billion against net assets of ₩168.26 Billion KRW. For live market cap and overall valuation, see 009420 stock market capitalisation.
Annual Strategic Asset Allocation Index for Hanall Biopharma (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Hanall Biopharma from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Hanall Biopharma for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 11.4% | ₩19.13 Billion | ₩19.13 Billion | ₩- | ₩168.26 Billion | ▼ -0.3 pp |
| 2021 | 11.6% | ₩19.04 Billion | ₩19.04 Billion | ₩- | ₩163.49 Billion | ▲ +3.1 pp |
| 2020 | 8.5% | ₩15.48 Billion | ₩15.48 Billion | ₩- | ₩181.27 Billion | ▼ -14.9 pp |
| 2019 | 23.4% | ₩32.87 Billion | ₩14.94 Billion | ₩17.93 Billion | ₩140.42 Billion | ▲ +6.4 pp |
| 2018 | 17.0% | ₩19.91 Billion | ₩13.77 Billion | ₩6.14 Billion | ₩116.92 Billion | ▲ +3.4 pp |
| 2017 | 13.6% | ₩15.14 Billion | ₩13.38 Billion | ₩1.76 Billion | ₩111.20 Billion | ▼ -1.3 pp |
| 2016 | 14.9% | ₩15.56 Billion | ₩13.78 Billion | ₩1.78 Billion | ₩104.36 Billion | ▲ +1.0 pp |
| 2015 | 13.9% | ₩13.24 Billion | ₩12.18 Billion | ₩1.06 Billion | ₩95.22 Billion | ▼ -12.6 pp |
| 2014 | 26.5% | ₩12.12 Billion | ₩11.86 Billion | ₩264.91 Million | ₩45.81 Billion | ▲ +4.6 pp |
| 2013 | 21.8% | ₩13.01 Billion | ₩12.20 Billion | ₩805.28 Million | ₩59.63 Billion | ▲ +8.5 pp |
| 2012 | 13.3% | ₩10.50 Billion | ₩10.50 Billion | ₩- | ₩78.67 Billion | ▼ -5.9 pp |
| 2011 | 19.3% | ₩9.78 Billion | ₩9.78 Billion | ₩- | ₩50.70 Billion | — |